coyatherapeutics.com
  • About Us
      • Back
      • Story and Approach
      • Management Team
  • Science & Technology
      • Back
      • Treg Overview
      • Manufacturing Overview
      • Exosome Overview
      • Publications
  • Pipeline
      • Back
      • Pipeline
      • Indications
  • News
      • Back
      • News
      • Press Releases
      • Blog
      • Presentations
      • Events
  • Patient Resources
      • Back
      • Clinical Trial Information
  • Contact Us
line

Regulatory T-lymphocytes Mediate Amyotrophic Lateral Sclerosis Progression And Survival

Harnessing adoptive
regulatory T cells (Tregs)
to target disease

Contact Us
Gantry 5
© 2022 Coya Therapeutics, Inc. All rights reserved
  • About Us
      • Back
      • Story and Approach
      • Management Team
  • Science & Technology
      • Back
      • Treg Overview
      • Manufacturing Overview
      • Exosome Overview
      • Publications
  • Pipeline
      • Back
      • Pipeline
      • Indications
  • News
      • Back
      • News
      • Press Releases
      • Blog
      • Presentations
      • Events
  • Patient Resources
      • Back
      • Clinical Trial Information
  • Contact Us
Terms of Use  Privacy Policy  

Follow Us

5850 San Felipe St Suite 500
Houston TX 77057
1 (800) 587-8170

Harnessing potent
immunomodulatory T cells (Tregs) and TREG derived
Exosomes to target disease

Contact Us